Keywords: vernalis, ceo, exits, losses, widen, uk-based, biotechnology
Vernalis CEO exits as losses widen in 2002
Article | 31 March 2003
UK-based biotechnology concern Vernalis saw its share price plummetMarch 21, as the company reported widening losses and announced that its chief ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
